Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 12:05 PM
Ignite Modification Date: 2025-12-24 @ 12:05 PM
NCT ID: NCT06398561
Eligibility Criteria: Selection and withdrawal of subjects Inclusion criteria: * People over 18 years of age. * Attending consultations with any of the professionals in the USM mental health network. * Having an active diagnostic label of Major Depressive Disorder, according to ICD or DSM criteria in the Primary Care e-SIAP program or meeting MINI TRAS criteria after individual interview for Major Depressive Episode. Exclusion criteria * People who present mental health disorders associated with a depressive disorder and who are in the acute phase of the disease. * People who are not under active follow-up with any of the professionals of the USM. * People with mobility problems and / or displacement to the health center. * People suffering from another disease affecting the CNS (organic brain pathology or who have suffered a severe head injury, onset dementia or any other neurodegenerative disease, etc.). * People with presence of uncontrolled serious medical, infectious or degenerative disease, which may interfere with affective symptomatology. * People with significant risk of suicide according to medical criteria, assessed through follow-up interviews conducted by mental health professionals of reference. * People with any medical, psychological and/or social problem that could seriously interfere with the patient's participation in the study. * People who are legally incapacitated to make health decisions.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 85 Years
Study: NCT06398561
Study Brief:
Protocol Section: NCT06398561